SK68597A3 - Kit for osteoporosis treatment cycle - Google Patents
Kit for osteoporosis treatment cycle Download PDFInfo
- Publication number
- SK68597A3 SK68597A3 SK685-97A SK68597A SK68597A3 SK 68597 A3 SK68597 A3 SK 68597A3 SK 68597 A SK68597 A SK 68597A SK 68597 A3 SK68597 A3 SK 68597A3
- Authority
- SK
- Slovakia
- Prior art keywords
- tiludronic acid
- nutritional supplement
- pharmaceutically acceptable
- acceptable salts
- calcium
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Physical Education & Sports Medicine (AREA)
- Orthopedic Medicine & Surgery (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Inorganic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Rheumatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR9414630A FR2727629A1 (fr) | 1994-12-06 | 1994-12-06 | Trousse pour cycle de traitement de l'osteoporose |
| PCT/FR1995/001596 WO1996017616A1 (fr) | 1994-12-06 | 1995-12-05 | Trousse pour cycle de traitement de l'osteoporose |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SK68597A3 true SK68597A3 (en) | 1997-11-05 |
Family
ID=9469504
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SK685-97A SK68597A3 (en) | 1994-12-06 | 1995-12-05 | Kit for osteoporosis treatment cycle |
Country Status (20)
| Country | Link |
|---|---|
| EP (1) | EP0797444A1 (fr) |
| JP (1) | JPH10509729A (fr) |
| KR (1) | KR980700083A (fr) |
| CN (1) | CN1168634A (fr) |
| AR (1) | AR002946A1 (fr) |
| AU (1) | AU4307396A (fr) |
| BR (1) | BR9509961A (fr) |
| CA (1) | CA2207028A1 (fr) |
| CZ (1) | CZ175397A3 (fr) |
| FI (1) | FI972383A0 (fr) |
| FR (1) | FR2727629A1 (fr) |
| HU (1) | HUT77382A (fr) |
| IL (1) | IL116168A0 (fr) |
| MA (1) | MA23737A1 (fr) |
| NO (1) | NO972558L (fr) |
| PL (1) | PL320564A1 (fr) |
| SK (1) | SK68597A3 (fr) |
| TR (1) | TR199501530A1 (fr) |
| WO (1) | WO1996017616A1 (fr) |
| ZA (1) | ZA9510184B (fr) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6432932B1 (en) | 1997-07-22 | 2002-08-13 | Merck & Co., Inc. | Method for inhibiting bone resorption |
| US5994329A (en) | 1997-07-22 | 1999-11-30 | Merck & Co., Inc. | Method for inhibiting bone resorption |
| PT1506041E (pt) | 2002-05-10 | 2007-12-28 | Hoffmann La Roche | Ácido ibandrónico para o tratamento e a prevenção da osteoporose |
| SI1790347T1 (sl) * | 2002-12-20 | 2015-03-31 | F. Hoffmann-La Roche Ag | Formulacija z visokim odmerkom ibandronata |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ATE114473T1 (de) * | 1984-04-30 | 1994-12-15 | Procter & Gamble | Ausrüstung für die verwendung bei der behandlung von osteoporose. |
| US4761406A (en) * | 1985-06-06 | 1988-08-02 | The Procter & Gamble Company | Regimen for treating osteoporosis |
| ATE161423T1 (de) * | 1992-06-30 | 1998-01-15 | Procter & Gamble Pharma | Verwendung von phosphinate zur behandlung der osteoporose |
| FR2694558B1 (fr) * | 1992-08-05 | 1994-10-28 | Sanofi Elf | Monohydrate du sel disodique de l'acide 4-chlorophénylthiométhylène bisphosphonique, sa préparation, les compositions pharmaceutiques en contenant. |
-
1994
- 1994-12-06 FR FR9414630A patent/FR2727629A1/fr active Granted
-
1995
- 1995-11-28 IL IL11616895A patent/IL116168A0/xx unknown
- 1995-11-30 ZA ZA9510184A patent/ZA9510184B/xx unknown
- 1995-12-04 MA MA24086A patent/MA23737A1/fr unknown
- 1995-12-04 TR TR95/01530A patent/TR199501530A1/xx unknown
- 1995-12-05 BR BR9509961A patent/BR9509961A/pt not_active Application Discontinuation
- 1995-12-05 HU HU9702097A patent/HUT77382A/hu unknown
- 1995-12-05 CZ CZ971753A patent/CZ175397A3/cs unknown
- 1995-12-05 CN CN95196670A patent/CN1168634A/zh active Pending
- 1995-12-05 JP JP8517359A patent/JPH10509729A/ja not_active Ceased
- 1995-12-05 AR ARP950100438A patent/AR002946A1/es unknown
- 1995-12-05 WO PCT/FR1995/001596 patent/WO1996017616A1/fr not_active Application Discontinuation
- 1995-12-05 KR KR1019970703784A patent/KR980700083A/ko not_active Application Discontinuation
- 1995-12-05 CA CA002207028A patent/CA2207028A1/fr not_active Abandoned
- 1995-12-05 EP EP95941761A patent/EP0797444A1/fr not_active Withdrawn
- 1995-12-05 PL PL95320564A patent/PL320564A1/xx unknown
- 1995-12-05 SK SK685-97A patent/SK68597A3/sk unknown
- 1995-12-05 AU AU43073/96A patent/AU4307396A/en not_active Abandoned
-
1997
- 1997-06-05 FI FI972383A patent/FI972383A0/fi not_active Application Discontinuation
- 1997-06-05 NO NO972558A patent/NO972558L/no unknown
Also Published As
| Publication number | Publication date |
|---|---|
| ZA9510184B (en) | 1996-06-11 |
| FI972383A (fi) | 1997-06-05 |
| NO972558D0 (no) | 1997-06-05 |
| PL320564A1 (en) | 1997-10-13 |
| CA2207028A1 (fr) | 1996-06-13 |
| WO1996017616A1 (fr) | 1996-06-13 |
| BR9509961A (pt) | 1997-11-25 |
| MA23737A1 (fr) | 1996-07-01 |
| CZ175397A3 (en) | 1997-10-15 |
| HUT77382A (hu) | 1998-04-28 |
| AR002946A1 (es) | 1998-05-27 |
| MX9704105A (es) | 1997-09-30 |
| AU4307396A (en) | 1996-06-26 |
| NO972558L (no) | 1997-08-05 |
| JPH10509729A (ja) | 1998-09-22 |
| IL116168A0 (en) | 1996-01-31 |
| FI972383A0 (fi) | 1997-06-05 |
| EP0797444A1 (fr) | 1997-10-01 |
| FR2727629B1 (fr) | 1997-02-28 |
| FR2727629A1 (fr) | 1996-06-07 |
| CN1168634A (zh) | 1997-12-24 |
| TR199501530A1 (tr) | 1996-10-21 |
| KR980700083A (ko) | 1998-03-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US6352713B1 (en) | Nutritional composition | |
| PT2133084E (pt) | Formulação farmacêutica que compreende compostos de lantânio | |
| EP0521388B1 (fr) | Procédé de préparation d'une composition pharmaceutique à base d'au mains deux principes actifs différents et utilisation d'une telle composition | |
| US4861590A (en) | Sustained release fluoride and calcium composition | |
| EP0304987A2 (fr) | Suppléments de calcium | |
| RU2261098C2 (ru) | Перорально распадающаяся композиция, содержащая миртазапин | |
| US4859467A (en) | Sustained release fluoride composition | |
| EP1651191B1 (fr) | Compositions pharmaceutiques effervescentes contenant de la vitamine d, du calcium et du phosphate et leur utilisation therapeutique | |
| US5013728A (en) | Composition for treating osteoporosis and hormonal imbalance | |
| JPS5938203B2 (ja) | 補酵素ｑを主成分とする脳循環障害治療剤 | |
| SK121699A3 (en) | Stable solid preparation containing vitamin d3 and tricalcium phosphate | |
| SK68597A3 (en) | Kit for osteoporosis treatment cycle | |
| US5932252A (en) | Method and composition for treatment of osteoporosis | |
| DE20321698U1 (de) | Medikament zur Erhöhung der Bioverfügbarkeit von Alendronat oder einem anderen Bisphosphonat durch Verabreichen einer Vordosis eines Vitamin-D-Derivats | |
| CA2219354A1 (fr) | Prevention des pertes de dnets par l'administration d'alendronate ou de ses sels | |
| US9623066B2 (en) | Compositions and methods to inhibit kidney stone growth | |
| EP1661575A1 (fr) | Utilisation de magnésium dans le traitement des troubles associés aux variations hormonales chez la femme | |
| US4517309A (en) | Method for the treatment of calcifying pancreatitis | |
| MXPA97004105A (en) | Set for use in a therapeutic treatment cycle of osteoporo | |
| RU2273492C1 (ru) | Композиция для профилактики и лечения болезней, вызываемых дефицитом кальция (варианты) | |
| RU2278667C2 (ru) | Состав, регулирующий метаболические процессы, и способ его получения | |
| EP0691814B1 (fr) | Procede et composition s'appliquant au traitement de l'osteoporose | |
| RU2273493C1 (ru) | Композиция для профилактики и лечения болезней, вызываемых дефицитом кальция (варианты) | |
| RU2271822C1 (ru) | Композиция для профилактики и лечения болезней, вызываемых дефицитом кальция (варианты) | |
| CA2159355C (fr) | Methode et composition pour le traitement de l'osteoporose |